These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7584094

  • 1. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.
    Chu TH, Martinez I, Sheay WC, Dornburg R.
    Gene Ther; 1994 Sep; 1(5):292-9. PubMed ID: 7584094
    [Abstract] [Full Text] [Related]

  • 2. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS, Moritz D, Jeschke M, Groner B.
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [Abstract] [Full Text] [Related]

  • 3. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
    Engelstädter M, Buchholz CJ, Bobkova M, Steidl S, Merget-Millitzer H, Willemsen RA, Stitz J, Cichutek K.
    Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
    [Abstract] [Full Text] [Related]

  • 4. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Höhne M, Thaler S, Dudda JC, Groner B, Schnierle BS.
    Virology; 1999 Aug 15; 261(1):70-8. PubMed ID: 10441556
    [Abstract] [Full Text] [Related]

  • 5. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
    Katane M, Fujita R, Takao E, Kubo Y, Aoki Y, Amanuma H.
    J Gene Med; 2004 Mar 15; 6(3):260-7. PubMed ID: 15026987
    [Abstract] [Full Text] [Related]

  • 6. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells.
    Pizzato M, Blair ED, Fling M, Kopf J, Tomassetti A, Weiss RA, Takeuchi Y.
    Gene Ther; 2001 Jul 15; 8(14):1088-96. PubMed ID: 11526456
    [Abstract] [Full Text] [Related]

  • 7. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer.
    Chu TH, Dornburg R.
    J Virol; 1995 Apr 15; 69(4):2659-63. PubMed ID: 7884919
    [Abstract] [Full Text] [Related]

  • 8. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
    Hatziioannou T, Russell SJ, Cosset FL.
    Virology; 2000 Feb 01; 267(1):49-57. PubMed ID: 10648182
    [Abstract] [Full Text] [Related]

  • 9. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
    Lin AH, Kasahara N, Wu W, Stripecke R, Empig CL, Anderson WF, Cannon PM.
    Hum Gene Ther; 2001 Mar 01; 12(4):323-32. PubMed ID: 11242525
    [Abstract] [Full Text] [Related]

  • 10. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
    Stitz J, Buchholz CJ, Engelstädter M, Uckert W, Bloemer U, Schmitt I, Cichutek K.
    Virology; 2000 Jul 20; 273(1):16-20. PubMed ID: 10891403
    [Abstract] [Full Text] [Related]

  • 11. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V, Muriaux D, Darlix JL, Cosset FL.
    J Virol; 2004 Jul 20; 78(13):7153-64. PubMed ID: 15194792
    [Abstract] [Full Text] [Related]

  • 12. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
    Zavorotinskaya T, Albritton LM.
    Mol Ther; 2001 Mar 20; 3(3):323-8. PubMed ID: 11273774
    [Abstract] [Full Text] [Related]

  • 13. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
    Kondo T, Ikeda K, Matsuo K.
    Bone; 2004 Nov 20; 35(5):1120-6. PubMed ID: 15542037
    [Abstract] [Full Text] [Related]

  • 14. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J, Steidl S, Merget-Millitzer H, König R, Müller P, Nocken F, Engelstädter M, Bobkova M, Schmitt I, Kurth R, Buchholz CJ, Cichutek K.
    Virology; 2000 Feb 15; 267(2):229-36. PubMed ID: 10662618
    [Abstract] [Full Text] [Related]

  • 15. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.
    Weijtens ME, Willemsen RA, Hart EH, Bolhuis RL.
    Gene Ther; 1998 Sep 15; 5(9):1195-203. PubMed ID: 9930320
    [Abstract] [Full Text] [Related]

  • 16. Retroviral targeted delivery.
    Schnierle BS, Groner B.
    Gene Ther; 1996 Dec 15; 3(12):1069-73. PubMed ID: 8986432
    [Abstract] [Full Text] [Related]

  • 17. Changes in a murine leukemia virus (MLV) receptor encoded by an alphavirus vector during passage in cells expressing the MLV envelope.
    Kazachkov Y, Long D, Wang C, Silver J.
    Virology; 2000 Feb 01; 267(1):124-32. PubMed ID: 10648189
    [Abstract] [Full Text] [Related]

  • 18. Tumor cell-specific gene transfer with retroviral vectors displaying single-chain antibody.
    Tang Y, Li Y, Qian G.
    Chin Med J (Engl); 2002 Jul 01; 115(7):1064-9. PubMed ID: 12150744
    [Abstract] [Full Text] [Related]

  • 19. In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies.
    Jiang A, Dornburg R.
    Gene Ther; 1999 Dec 01; 6(12):1982-7. PubMed ID: 10637449
    [Abstract] [Full Text] [Related]

  • 20. Targeting of retroviral vectors through protease-substrate interactions.
    Nilson BH, Morling FJ, Cosset FL, Russell SJ.
    Gene Ther; 1996 Apr 01; 3(4):280-6. PubMed ID: 8732159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.